Table of Contents

• R M Anderson and
• L S Robins

How do we know? Reflections on qualitative research in diabetes.

• M C Riddle

Learning to use troglitazone.

• A C Larme and
• J A Pugh

Attitudes of primary care providers toward diabetes: barriers to guideline implementation.

• A Branchi,
• A Rovellini,
• A Torri,
• and D Sommariva

Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patients.

• R M Anderson,
• J T Fitzgerald,
• M M Funnell,
• and L D Gruppen

The third version of the Diabetes Attitude Scale.

• S F Dinneen,
• D Maldonado, 3rd,
• C L Leibson,
• G G Klee,
• H Li,
• L J Melton, 3rd,
• and R A Rizza

Effects of changing diagnostic criteria on the risk of developing diabetes.

• H King,
• R E Aubert,
• and W H Herman

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

• G L Beckles,
• M M Engelgau,
• K M Narayan,
• W H Herman,
• R E Aubert,
• and D F Williamson

Population-based assessment of the level of care among adults with diabetes in the U.S.

• A Nicolucci,
• F Carinci,
• and A Ciampi

Stratifying patients at risk of diabetic complications: an integrated look at clinical, socioeconomic, and care-related factors. SID-AMD Italian Study Group for the Implementation of the St. Vincent Declaration.

• M R Pastore,
• E Bazzigaluppi,
• R Bonfanti,
• N Dozio,
• A Sergi,
• A Balini,
• C Belloni,
• F Meschi,
• E Bonifacio,
• and E Bosi

Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives.

• M Yamamoto,
• G Egusa,
• M Okubo,
• and M Yamakido

Dissociation of microangiopathy and macroangiopathy in patients with type 2 diabetes.

• J B Buse,
• B Gumbiner,
• N P Mathias,
• D M Nelson,
• B W Faja,
• and R W Whitcomb

Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group.

• E S Horton,
• F Whitehouse,
• M N Ghazzi,
• T C Venable,
• and R W Whitcomb

Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.

• H Shimizu,
• T Tsuchiya,
• N Sato,
• Y Shimomura,
• I Kobayashi,
• and M Mori

Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients.

• F Q Nuttall

Comparison of percent total GHb with percent HbA1c in people with and without known diabetes.

• K J Wientjes,
• P Vonk,
• Y Vonk-van Klei,
• A J Schoonen,
• and N W Kossen

Microdialysis of glucose in subcutaneous adipose tissue up to 3 weeks in healthy volunteers.

• P Damsbo,
• L S Hermann,
• A Vaag,
• O Hother-Nielsen,
• and H Beck-Nielsen

Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.

• T Takahashi,
• Y Nishizawa,
• M Emoto,
• T Kawagishi,
• N Matsumoto,
• E Ishimura,
• M Inaba,
• Y Okuno,
• H Shimada,
• and H Morii

Sympathetic function test of vasoconstrictor changes in foot arteries in diabetic patients.

• J P Le Floch,
• C Herbreteau,
• F Lange,
• and L Perlemuter

Biologic material in needles and cartridges after insulin injection with a pen in diabetic patients.

• A Fritsche,
• M Stumvoll,
• M Grüb,
• S Sieslack,
• W Renn,
• R M Schmülling,
• H U Häring,
• and J E Gerich

Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects.

• S K Jain,
• K S Krueger,
• R McVie,
• J J Jaramillo,
• M Palmer,
• and T Smith

Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide levels in type 1 diabetic patients.

• A Pérez,
• G Carreras,
• A Caixàs,
• A Castellví,
• A Caballero,
• R Bonet,
• J Ordóñez-Llanos,
• and A de Leiva

Plasma lipoprotein(a) levels are not influenced by glycemic control in type 1 diabetes.

• S P Silveiro,
• L A da Costa,
• M O Beck,
• and J L Gross

Urinary albumin excretion rate and glomerular filtration rate in single-kidney type 2 diabetic patients.

• M Daimon,
• S Susa,
• K Yamatani,
• H Manaka,
• K Hama,
• M Kimura,
• H Ohnuma,
• and T Kato

Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes.

• A Ceriello,
• N Bortolotti,
• E Motz,
• A Crescentini,
• S Lizzio,
• A Russo,
• L Tonutti,
• and C Taboga

Meal-generated oxidative stress in type 2 diabetic patients.

• A Sato,
• L Tarnow,
• and H H Parving

Increased left ventricular mass in normotensive type 1 diabetic patients with diabetic nephropathy.

• D S Dalton,
• K J Cruickshanks,
• R Klein,
• B E Klein,
• and T L Wiley

Association of NIDDM and hearing loss.

• L H Canani,
• F Gerchman,
• and J L Gross

Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy.

Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association.

• Z T Bloomgarden

International Diabetes Federation meeting, 1997: nephropathy, retinopathy, and glycation.

• P G Pickstock and
• B M Singh

Assessing dependency in insulin-treated patients with diabetes supported by a community nursing service.

• L Spallino,
• H F Stirling,
• M O'Regan,
• L Ross,
• M Zampolli,
• and C J Kelnar

Transient hypoglycemic hemiparesis in children with IDDM.

• F J Snoek,
• N van der Veer,
• R J Heine,
• and E H de Haan

No differences in attentional functioning between type 1 diabetic patients with and without a history of severe hypoglycemia.

• T Awata,
• S Kurihara,
• K Inoue,
• I Inoue,
• S Takei,
• C Ishii,
• K Negishi,
• K Namai,
• Y Kanazawa,
• T Kuzuya,
• and S Katayama

A novel missense mutation in the homeodomain of the hepatocyte nuclear factor-1alpha/maturity-onset diabetes of the young 3 in a Japanese early-onset type 2 diabetic patient and time-course of glucose-stimulated insulin secretion.

• A Carpentier,
• J Wither,
• B Vukusic,
• K Lawday,
• A H Boss,
• and G F Lewis

An epitaph for sulfated insulin: immunologic profile of the last patients as they are switched from sulfated beef to human insulin.

• M M Albareda,
• A Wägner,
• M Puig,
• and R Corcoy

Is diabetic ketoacidosis a cause of meningeal syndrome? Case report.

• M Hummel,
• P Banholzer,
• W Rabl,
• and A G Ziegler

Organospecific lymph node enlargement in autoimmune polyglandular syndrome.

• P Darmon,
• C Curtillet,
• S Boullu,
• A Laugier,
• A Dutour,
• and C Oliver

Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.

• C J Wu and
• W H Sheu

Type 2 diabetes in adults with pseudopseudohypoparathyroidism. Case report.

• L M Thaler,
• I M El-Kebbi,
• D C Ziemer,
• D L Gallina,
• V G Dunbar,
• and L S Phillips

High prevalence of albuminuria among African-Americans with short duration of diabetes.

• M Roubicek,
• G Viñes,
• and A González Sanguineti

Use of HbA1c in screening for diabetes.

• M S Eberhardt and
• K M Flegal

Assessing the utility of glycated hemoglobin.

• T Cundy,
• L Ducker,
• K Wrathall,
• and J Morrison

Agreement between old and new diagnostic criteria in postpartum testing of women with gestational diabetes.